Over half of new cancer drugs ‘show no benefits’ for survival or wellbeing

Hepatitis C condition still stigmatising, says support group
November 1, 2017
Dealing with Crohn’s Disease and Loose Stools | Everyday Health
November 2, 2017
Show all

Over half of new cancer drugs ‘show no benefits’ for survival or wellbeing

Checking in on the effectiveness of new cancer medications.

Most cancer drugs that have recently arrived on the market have come with little evidence that they boost the survival or wellbeing of patients, research reveals.

Forty-eight cancer drugs were approved by the European Medicines Agency between 2009 and 2013 for use as treatments in 68 different situations.

But the study, which looked at the clinical trials associated with the drugs, reveals that at the time the therapies became available there was no conclusive evidence that they improved survival in almost two-thirds of the situations for which they were approved.

In only 10% of the uses did the drugs improve quality of life. Overall 57% of uses showed no benefits for either survival or quality of life.

Read full article: Over half of new cancer drugs ‘show no benefits’ for survival or wellbeing | Business | The Guardian

Read Full Article: Over half of new cancer drugs ‘show no benefits’ for survival or wellbeing | Business | The Guardian

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.